Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An investigator initiated Phase 2 clinical trial of AB569 in patients with chronic lung infection caused by P. aeruginosa and other bacterial pathogens in COPD and/or CF

X
Trial Profile

An investigator initiated Phase 2 clinical trial of AB569 in patients with chronic lung infection caused by P. aeruginosa and other bacterial pathogens in COPD and/or CF

Status: Planning
Phase of Trial: Phase II

Latest Information Update: 03 Apr 2018

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Nitrite (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 27 Mar 2018 According to an Arch Biopartners media release, the clinical team at Cincinnati Veterans Affairs Medical Center (CVAMC), in association with the University of Cincinnati College of Medicine plans to initiate this trial.
    • 14 Nov 2016 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top